Tag: the affordable care act

Northwell Health Lab Team Leverages Data to Add Value

By Joseph Burns, from the Volume XXVI No. 8 – June 10, 2019 issue

CEO SUMMARY: Today, insurers get risk-adjusted payments for treating patients who have high-cost health conditions and they make risk-adjusted payments to physicians, hospitals, and other providers. At Northwell Health, the clinical lab saw the opportunity to leverage lab test data with other clinical and demographic data to identify patients who were undiagnosed or whose conditions were

View Article

Morgan Stanley Report Shows 8% of Hospitals at Risk of Closure

By Joseph Burns, from the Volume XXV No. 13 – September 10, 2018 issue

AMONG THE ROUGHLY 6,500 HOSPITALS OPERATING in the United States, only about 125 (2.5%) have closed in the past five years. But in the coming years, some 450 hospitals are at risk of closing. Analysts at Morgan Stanley said 600 other hospitals have weak finances that could lead them to close.

In the report, Morgan Stanley,

View Article

Newsmaker Interview: Healthcare’s Transformation Now Bringing Changes to Lab Industry

By Joseph Burns, from the Volume XXV No. 3 – February 12, 2018 issue

“Today, patients want to get diagnosis and treatment faster with fewer visits to the doctor’s office. They want speedier and more comprehensive delivery of clinical services, be it laboratory tests, imaging, or other procedures.”

—Ralph Taylor, President, Sysmex America, Inc.

CEO Summary: To bring testing closer to patients, clinical laboratories will need to offer sophisticated point-of-care systems

View Article

Value-Based Care Is One Goal Of WHCN-Sonic Lab JV

By Joseph Burns, from the Volume XXIV, No. 4 – March 13, 2017 issue

CEO SUMMARY: Announced last month, the new laboratory joint-venture partnership with Sonic Healthcare’s Sunrise Clinical Laboratories will allow WCHN to compete with other health systems and prepare to respond to health insurers’ requests that hospital systems offer lower rates in value-based payment models. WCHN has already seen payers shift to low-cost providers. For this reason,

View Article

Theranos implosion was the first Big Story of 2016

By Mary Van Doren, from the Volume XXIII No. 17 – December 19, 2016 issue

This is an excerpt from a 3,200-word article in the December 19 issue of THE DARK REPORT. The complete article is available for a limited time to all readers, and available at all times to paid members of the Dark Intelligence Group.
CEO SUMMARY: THE DARK REPORT’S annual list of the Lab Industry’s Top 10 stories for

View Article

Much Disruption for Labs In 2016’s Top 10 Stories

By Robert Michel, from the Volume XXIII No. 17 – December 19, 2016 issue

CEO SUMMARY: Within THE DARK REPORT’S list of the Top 10 Lab Industry Stories for 2016 is one story of disruption that might have been one story of disruption about to happen. The disintegration of Theranos during 2016 is the big story about a self-proclaimed disruptor of the lab industry that finds itself struggling just

View Article

Strategy Lowers CalPERS’ Price of Joint Surgeries

By Joseph Burns, from the Volume XXIII No. 12 – September 6, 2016 issue

CEO SUMMARY: Probably the most-watched reference pricing program in healthcare to date was initiated by CalPERS. It focused on the variability in the prices of knee and hip replacement surgeries. Just as Safeway experienced a drop in clinical lab test prices of 32% in its reference pricing program, CalPERs paid 30% less for these surgeries

View Article

Gene Testing Lab Goes ‘Cold Turkey,’ Stops Billing Health Plans

By Joseph Burns, from the Volume XXIII, No. 6 - May 2, 2016 issue

CEO SUMMARY: Last year, Kailos Genetics stopped collecting third-party payment, dropped its prices sharply, and started marketing its genetic-screening tests directly to consumers and physicians. At the time, 100% of its revenue came from third-party payers. Today, it gets 100% of its revenue from consumers. After eliminating third-party payment, revenue dropped precipitously, but is now

View Article

Lab CEO Sees Three Trends Cutting Volume, Revenue

By Joseph Burns, from the Volume XXIII No. 4 – March 21, 2016 issue

CEO SUMMARY: Following the sale of his hospital lab outreach business to a national lab company, former CEO James Fantus told THE DARK REPORT about the significant trends he saw unfolding in the Northeast. They include: a shrinking number of physician customers for labs; a rising number of patients with high-deductible health plans, resulting in

View Article

New DAT Law, Competition Heat Up Phoenix Market

By Joseph Burns, from the Volume XXII NO. 15 - October 26, 2015 issue

CEO SUMMARY: In Arizona, Theranos supported a new state law this year that allows patients to order lab tests without a doctor’s order. Since the law took effect, that law and the ultra-low prices offered by Theranos are drawing away some cash-paying customers from one lab company that has operated in Phoenix for 26 years.

View Article

Volume XXVI No. 8 – June 10, 2019

THE U.S. HAS LOST ALMOST 18% of its pathologists since 2007. This means the U.S. has even fewer pathologists than other countries who have already suffered adverse clinical lab quality events. TDR also digs further into what this means for the industry, finding that while salaries and benefits are increasing, higher pay will come with a heavier workload. Also, in a Clinical Lab 2.0 case study, TDR walks readers through the steps Northwell Health took to help improve patient care – and add value – by using its data to identify patients who were undiagnosed or misdiagnosed.

See the full table of contents

Tag: the affordable care act

Enter Your Login Credentials